- Home
- TORO vs ICCC Comparison
TORO vs ICCC Comparison
Compare TORO & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TORO
- ICCC
- Stock Information
- Founded
- TORO 2022
- ICCC 1982
- Country
- TORO Cyprus
- ICCC United States
- Employees
- TORO N/A
- ICCC N/A
- Industry
- TORO Marine Transportation
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- TORO Consumer Discretionary
- ICCC Health Care
- Exchange
- TORO Nasdaq
- ICCC Nasdaq
- Market Cap
- TORO 67.1M
- ICCC 55.5M
- IPO Year
- TORO N/A
- ICCC 1987
- Fundamental
- Price
- TORO $3.79
- ICCC $4.72
- Analyst Decision
- TORO
- ICCC
- Analyst Count
- TORO 0
- ICCC 0
- Target Price
- TORO N/A
- ICCC N/A
- AVG Volume (30 Days)
- TORO 47.8K
- ICCC 22.7K
- Earning Date
- TORO 11-14-2025
- ICCC 11-13-2025
- Dividend Yield
- TORO N/A
- ICCC N/A
- EPS Growth
- TORO N/A
- ICCC N/A
- EPS
- TORO 0.01
- ICCC 0.26
- Revenue
- TORO $20,143,992.00
- ICCC $27,769,304.00
- Revenue This Year
- TORO N/A
- ICCC N/A
- Revenue Next Year
- TORO N/A
- ICCC N/A
- P/E Ratio
- TORO $288.59
- ICCC $17.66
- Revenue Growth
- TORO 0.40
- ICCC 16.49
- 52 Week Low
- TORO $1.70
- ICCC $3.40
- 52 Week High
- TORO $4.94
- ICCC $7.60
- Technical
- Relative Strength Index (RSI)
- TORO 48.89
- ICCC 29.17
- Support Level
- TORO $3.58
- ICCC $4.56
- Resistance Level
- TORO $3.85
- ICCC $6.36
- Average True Range (ATR)
- TORO 0.23
- ICCC 0.27
- MACD
- TORO -0.01
- ICCC -0.17
- Stochastic Oscillator
- TORO 45.57
- ICCC 11.67
About TORO Toro Corp.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.